Opioid-free Anesthesia vs. Opioid-based Anesthesia in Shoulder Arthroscopy
Key Findings:
Opioid-free anesthesia (OFA) with esketamine-dexmedetomidine significantly reduced postoperative nausea and vomiting (PONV) compared to opioid-based anesthesia (OBA) with propofol-remifentanil. Patients in the OFA group also experienced shorter post-anesthesia care unit (PACU) stays.
Practical Solutions:
Implementing OFA with esketamine-dexmedetomidine can help reduce PONV and streamline postoperative recovery for shoulder arthroscopy patients. Additionally, ultrasound-guided interscalene brachial plexus block (ISBPB) was used for postoperative analgesia in both groups.
Value:
This research demonstrates the feasibility of OFA with esketamine-dexmedetomidine as an alternative to traditional OBA for shoulder arthroscopy, offering potential benefits in terms of reducing PONV and PACU duration.
Clinical Trial Platform:
DocSym, an AI-driven platform, consolidates ICD-11 standards, clinical protocols, and research into an easily accessible knowledge base for clinicians, supporting the translation of clinical trial findings into everyday medical practice.
Streamlining Healthcare Operations:
Mobile apps provided by DocSym support scheduling, treatment monitoring, and telemedicine, facilitating efficient patient care management and digital service expansion in the healthcare environment.
AI Integration for Workflow Enhancement:
AI technology can improve clinic workflows, enhance patient outcomes, and reduce paper-based routines. Visit aidevmd.com to learn more about how DocSym can support healthcare facilities.
